Rossari Biotech Ltd.

NSE: ROSSARI BSE: 543213 SECTOR: Chemicals

1421.6
-58 (-3.92%)
NSE: 20 Sep 04:12 PM

Price Summary

Today's High

₹ 1477.15

Today's Low

₹ 1411

52 Week High

₹ 1593

52 Week Low

₹ 740.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

7826.56 Cr.

Enterprise Value

7740.58 Cr.

No. of Shares

5.51 Cr.

P/E

93.45

P/B

10.84

Face Value

₹ 2

Div. Yield

0.03%

Book Value (TTM)

₹  131.19

CASH

85.98 Cr.

DEBT

0 Cr.

Promoter Holding

68.7%

EPS (TTM)

₹  15.21

Sales Growth

15.05%

ROE

23.08 %

ROCE

28.88 %

Profit Growth

20.73 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Ratios

Sales Growth

1 Year15.05%
3 Year65.02%
5 Year44.53%

Profit Growth

1 Year20.73%
3 Year177.7%
5 Year90.09%

ROE%

1 Year23.08%
3 Year33.07%
5 Year33.44%

ROCE %

1 Year28.88%
3 Year41.14%
5 Year38.42%

Debt/Equity

0

Price to Cash Flow

150.24

Interest Cover Ratio

36.4271390374332

CFO/PAT (5 Yr. Avg.)

1.02476945020431

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2021 68.7 0
Mar 2021 72.69 0
Dec 2020 72.69 0
Sep 2020 72.69 0
Sep 2019 100 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 177.697502448927% for the Past 3 years.
  • The company has shown a good revenue growth of 65.0185464481341% for the Past 3 years.
  • The company has significantly decreased its debt by 66.929 Cr.
  • Company has been maintaining healthy ROE of 33.0720892933847% over the past 3 years.
  • Company has been maintaining healthy ROCE of 41.1410731343743% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 36.4271390374332.
  • The company has an efficient Cash Conversion Cycle of 28.0855944554348 days.
  • Company has a healthy liquidity position with current ratio of 2.21109259527605.
  • The company has a good cash flow management; CFO/PAT stands at 1.02476945020431.
  • The company has a high promoter holding of 68.7%.

 Limitations

  • The company is trading at a high PE of 93.45.
  • The company is trading at a high EV/EBITDA of 56.3596.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Net Sales 109.47 173.71 205.76 201.48 203.95
Total Expenditure 85.48 143.67 173.35 167.06 173.58
Operating Profit 23.99 30.04 32.41 34.42 30.37
Other Income 1.58 4.99 1.1 2.54 3.28
Interest 1.14 0.69 0.36 0.8 0.62
Depreciation 3.83 5.45 5.86 6.94 6.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 20.61 28.88 27.29 29.22 27
Tax 5.33 7.1 6.65 7.82 7.08
Profit After Tax 15.28 21.79 20.64 21.4 19.92
Adjusted EPS (Rs) 3.01 4.2 3.98 4.12 3.63

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2014 Mar 2015 Mar 2019 Mar 2020 Mar 2021
Net Sales 137.24 153.64 515.92 600.09 690.41
Total Expenditure 123.95 140.25 438.28 495.09 569.56
Operating Profit 13.29 13.39 77.64 105.01 120.86
Other Income 0.23 0.2 1.27 3.63 10.21
Interest 4.67 4.28 3.27 3.68 2.99
Depreciation 4.66 4.62 12.19 16.85 22.07
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.19 4.7 63.45 88.11 106
Tax 0.56 1 17.66 22.59 26.9
Net Profit 3.62 3.69 45.79 65.52 79.1
Adjusted EPS (Rs.) 8.23 8.4 104.07 12.91 15.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 4.4 4.4 4.4 10.15 10.39
Total Reserves 56.19 85.11 115.94 273.32 394.06
Borrowings 2.43 1.29 0.67 33.96 0
Other N/C liabilities 2.18 2.24 36.51 35.11 57.68
Current liabilities 55.96 66.1 123.91 168.83 165.62
Total Liabilities 121.16 159.13 281.43 521.37 627.75
Assets
Net Block 36.89 43.74 74 93.54 170.75
Capital WIP 7.9 9.99 2.83 21.75 0.32
Intangible WIP 0 0 0 0 0
Investments 0.2 3.2 0.23 4.65 9.25
Loans & Advances 0.89 1.94 38.59 58.17 61.57
Other N/C Assets 0 0 7.39 0.42 19.65
Current Assets 75.28 100.27 158.39 342.84 366.21
Total Assets 121.16 159.13 281.43 521.37 627.75
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2013 Mar 2014 Mar 2019 Mar 2020 Mar 2021
Profit from operations 3.37 4.19 63.45 88.11 106
Adjustment 9.76 9.29 16.55 20.17 18.41
Changes in Assets & Liabilities 9.11 -1.75 11.87 -32.38 -41.39
Tax Paid -0.18 -0.56 -20.32 -20.15 -30.93
Operating Cash Flow 17 6.24 71.55 55.75 52.09
Investing Cash Flow 9.17 -9.3 -40.6 -187.25 -37
Financing Cash Flow -25.9 2.89 -25.83 154.97 -29.45
Net Cash Flow 0.28 -0.18 5.12 23.46 -14.36

Corporate Actions

Investors Details

PARTICULARS Sep 2019 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Promoters 100 72.69 72.69 72.69 68.7
anita menezes 2.16 1.93 1.93 1.93 1.82
edward menezes 44.38 31.04 31.04 31.04 29.34
jyotishna chari 2.17 0 0 0 0
mikhail menezes 0.34 0.26 0.26 0.26 0.24
rossari biotech india pvt... 6.23 0 0 0 0
sunil chari 44.38 0 0 0 0
total 100 0 0 0 0
yash chari 0.34 0 0 0 0
chari family trust - in t... 0 0.21 0 0.21 0.2
jyotishna sunil chari 0 1.93 1.93 1.93 1.82
menezes family trust - in... 0 0.21 0 0.21 0.2
rossari biotech india pri... 0 5.81 0 0 0
sunil srinivasan chari 0 30.98 30.98 30.98 29.28
yash sunil chari 0 0.32 0.32 0.32 0.3
chari family trust - in t... 0 0 0.21 0 0
menezes family trust - in... 0 0 0.21 0 0
rossari biotech india pvt... 0 0 5.81 5.81 5.49
PARTICULARS Sep 2019 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Public 0 8.17 7.26 7.61 9.88
plutus wealth management ... 0 1.73 1.93 1.44 1.37
india acorn fund ltd 0 0 0 0 1.28
plutus wealth management ... 0 1.73 1.93 1.44 1.37
PARTICULARS Sep 2019 Sep 2020 Dec 2020 Mar 2021 Jun 2021
FII/DII 0 19.15 20.05 19.7 21.42
goldman sachs india limit... 0 1.31 1.28 1.28 1.21
invesco trustee private l... 0 1.68 0 0 0
principal trustee co. pvt... 0 1.89 1.77 1.56 1.2
sbi small cap fund 0 5.89 5.51 5.51 7.02
uti - equity fund 0 0 1.55 0 0
stichting depositary apg ... 0 0 0 1.62 1.66
taiyo greater india fund ... 0 0 0 1.09 1.29
uti flexi cap fund 0 0 0 1.76 1.9
malabar india fund limite... 0 0 0 0 1.11

Ratings & Research Reports

Company Presentations

Rossari Biotech Stock Price Analysis and Quick Research Report. Is Rossari Biotech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Rossari Biotech has a PE ratio of 93.4513088179224 which is high and comparatively overvalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Rossari Biotech has ROA of 13.7674285843577 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Rossari Biotech has a Current ratio of 2.21109259527605 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Rossari Biotech has a ROE of 23.0848251025804 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Rossari Biotech has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Rossari Biotech has an Inventory turnover ratio of 9.56548118153125 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Rossari Biotech has reported revenue growth of 15.0509753471956 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Rossari Biotech for the current financial year is 17.5047145625668 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Rossari Biotech is Rs 0.5 and the yield is 0.0347 %.

Brief about Rossari Biotech

X